Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polaroid-Behring Diagnostics was a joint venture established in 1991 between the Polaroid Corporation and Behringwerke AG, a subsidiary of Hoechst. The entity was created to develop and commercialize advanced clinical chemistry analyzers that integrated Polaroid's proprietary film and imaging technologies with Behring's expertise in biochemical reagents. Their flagship product was a desktop diagnostic system designed for use in decentralized settings such as physician office laboratories and small clinics. The system utilized a unique dry-chemistry format that allowed for rapid testing without the need for complex liquid handling. Despite the innovative approach to point-of-care testing, the venture was eventually dissolved in the mid-1990s as Polaroid shifted its strategic focus away from the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polaroid-Behring Diagnostics.